C-MAF Oncogene Dysregulation in Multiple Myeloma: Frequency and Biological Relevance

References

• Feirunan, R., Sawyer, J., Hardin, J. and Tricot, G. (1997) "Cytogenetics and molecular genetics in multiple myeloma", Hematology Oncology Clinical North Amerika 11, 1–24.
   PubMed Web of Science ®Google Scholar
• Pérez-Simón, J.A., Garcia-Sanz, R., Tabemo, M.D., Ahneida, J., Gonzalez, M., Fernández-Calvo, J., Moro, M.J., Hernandez, J.M., San, M.J.F. and Orfão, A. (1998) "Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes", Blood 91, 3366–3371.
   PubMed Web of Science ®Google Scholar
• Chesi, M., Bergsagel, P.L., Brents, L.A., Smith, CM., Gerhard, D.S. and Kuehl, W.M. (1996) "Dysregulation of Cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell tines", Blood 88, 674–681.
   PubMed Web of Science ®Google Scholar
• Chesi, M., Nardini, E, Brents, L.A., Schrock, E., Ried, T., Kuehl, W.M. and Bergsagel, P.L. (1997) "Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3", Nature Genetics 16, 260–264.
   PubMed Web of Science ®Google Scholar
• Richelda, R., Ronchetti, D., Baldini, L., Cro, L., Viggiano, L., Marzella, R., Rocchi, M., Otsuld, T., Lombardi, L., Maiolo, A.T. and Neri, A. (1997) "A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene", Blood 90, 4062–4070.
   PubMed Web of Science ®Google Scholar
• Chesi, M., Nardini, E., Lim, R.S., Smith, K.D., Kuehl, W.M. and Bergsagel, P.L. (1998) "The 04;14) translocation in myeloma dysregulaies both FGFR3 and a novel gene, 1VIMSET, resulting in IgH/MMSET hybrid transcripts", Blood 92, 3025–3034.
   PubMed Web of Science ®Google Scholar
• Iida, S., Rao, P.H., Butler, M., Corradini, P., Boccadoro, M., Klein, B., Chaganti, R.S. and Dalla-Favera, R. (1997) "Deregulation of MUMUIRF4 by chromosomal translocation in multiple myeloma", Nature Genetics 17, 226–230.
   PubMed Web of Science ®Google Scholar
• Chesi, M„ Bergsagel, P.L., Shonukan, 0.0., Martelli, M.L., Brents, L.A., Chen, T., Schrock, E., Ried, T. and Kuehl, W.M. (1998) "Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma", Blood 91, 4457–4463.
   Google Scholar
• Gazdar, A.F., Oie, H.K., Kirsch, I.R. and Hollis, G.F. (1986) "Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene", Blood 67, 1542–1549.
   PubMed Web of Science ®Google Scholar
• Avet-Loiseau, H., Li, J.Y., Facon, T., Brigaudeau, C., Morineau, N., Maloisel, F., Rapp, MJ., Talmant, P., Trimoreau, F., Jaccard, A., Harousseau, J.L. and Bataille, R. (1998) "High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies", Blood 92, 716a.
   Web of Science ®Google Scholar
• Avet-Loiseau, H., Facon, T., Grosbois, B., Magrangeas, F., Rapp, M.J., Harousseau, J.L., MinvielIe, S. and Bataille, R. (2002) "Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation", Blood 99, 2185–2191.
   PubMed Web of Science ®Google Scholar
• Nishizawa, M., Kataoka, K., Goto, N. and Fujiwara, K.T. (1989) "v-maf, a viral oncogene that encodes a "leucine zipper" motif', Proceedings of National Acadamic Science USA 86, 7711–7715.
   Google Scholar
• Rengarajan, J., Szabo, Si. and Glimcher, L.H. (2000) "Transcrip-tional regulation of Thl/Th2 polarization", Immunology Today 21, 479–483.
   PubMedGoogle Scholar
• Ho, I.-C., Lo, D. and Glinicher, L.H. (1998) "c-rnaf Promotes T helper cell type 2 (Th2) and attenuates Thl differentiation by both interleulcin 4-dependent and-independent mechanisms", Journal of Experimental Medicine 188, 1859–1866.
   PubMed Web of Science ®Google Scholar
• Rasmussen, T., Jensen, L. and Johnsen, H.E. (2001) "The clonal hierachy in multiple myeloma", Acta Oncologica 39, 765–770.
   Web of Science ®Google Scholar
• Harada, H., Kawano, M.M., Huang, N., Harada, Y., Iwato, K., Tanabe, 0., Tanaka, H., Sakai, A., Asaoku, H. and Kuramoto, A. (1993) "Phenotypic difference of normal plasma cells from mature myeloma cells", Blood 81, 2658–2663.
   PubMed Web of Science ®Google Scholar
• San, M.J., Garcia-Sans, R., Gonzalez, M. and Orfao, A. (1995) "Immunophenotype and DNA cell content in multiple myeloma", Baillieres Clinical Haematology 8, 735–759.
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck, C., Bataille, R., Robillard, N., Harousseau, J.L., Rapp, M.J., Juge-Morineau, N., Wlidenes, J. and Amiot, M. (1994) "Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells", Blood 84, 2597–2603.
   PubMed Web of Science ®Google Scholar
• Ocqueteau, M., Orfao, A., Garcia-Sanz, R., Almeida, J., Gonzalez, M. and San, M.J. (1996) "Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells", British Journal of Haematology 95, 489–493.
   PubMed Web of Science ®Google Scholar
• Bergsagel, P.L., Chesi, M., Nardini, E., Brents, L.A., Kirby, S.L. and Kuehl, W.M. (1996) "Promiscuous translocations into iminuno-globulin heavy chain switch regions in multiple myeloma", Proceedings of NationalAcadamic Science USA 93, 13931–13936.
   PubMed Web of Science ®Google Scholar
• Gooding, R.P., Bybee, A., Cooke, E, Little, A., Marsh, S.G.E., Coelho, E., Gupta, D., Samson, D. and Apperley, J.F. (1999) "Phenotypic and molecular analisis of six human cell lines derived from patients with plasmacell dyscrasia", British Journal of Haematology 106, 669–681.
   PubMed Web of Science ®Google Scholar